|
Mobile
versionAdvertisement
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACOG: Screen All Women for Alcohol Use Obstetrics & Gynecology Share    
Pregnant or not, all women seeing their ob/gyn should be screened for alcohol use to identify at-risk drinking and alcohol dependence, according to a new opinion from the American College of Obstetricians and Gynecologists. More Advertisement
 A New Resource From ASAM: Principles of Addiction Medicine, The Essentials ASAM Share
Culled from the authoritative resource on addiction medicine, Principles of Addiction Medicine, 4th Edition, is a new book which provides a quick reference on virtually all addiction medicine topics. This handbook offers up-to-date, clinically relevant information in a clear and concise form for a wide variety of practitioners, and is an invaluable resource for a wide variety of practitioners who have patients suffering from addictions. The book is just $67.95 and can be ordered online at http://www.lww.com/product/?978-1-60547-776-3 or by calling 800.638.3030. ASAM's 2011 Course on the 'State of the Art in Addiction Medicine' is now open ASAM Share
This course is designed specifically for the physician or other health care professional who seeks an advanced level of knowledge about recent breakthroughs in understanding, preventing, diagnosing and treating addiction and co-occurring medical and psychiatric disorders. It will be held Oct. 27-29 in Washington, DC, at the Washington Hilton Hotel. Register now and earn continuing medical education credits while learning about the latest research and treatments for addiction medicine. More  Novel Therapies for Cognitive Dysfunction Secondary to Substance Abuse Psychiatric Times (free registration required) Share
Advances in the fields of neuropsychological assessment and neuroimaging have enormously expanded our knowledge about the profile and severity of cognitive deficits in patients with substance use disorders. Neuroscience studies have complemented this knowledge by revealing the neural adaptations induced by different substances. More Prevention of Prescription Opioid Abuse: The Role of the Dentist The Journal of the American Dental Association (free abstract) Share
Dentists, along with other prescribers, need to take steps to identify problems and minimize prescription opioid abuse through greater prescriber and patient education; use of peer-reviewed recommendations for analgesia; and, when indicated, the tailoring of the appropriate and legitimate prescribing of opioids to adequately treat pain. More Prescription Misuse: Common but Doctors Can Change It Medscape (free registration required) Share
Although more recent research has identified some particular trends in terms of the demographics of individuals who misuse drugs, it is also important to understand personal and motivational variables associated with prescription misuse. Better knowledge regarding these factors may help physicians to identify patients at high risk for prescription misuse and also design more effective interventions to prevent drug misuse. More Advertisement
Treatment of Chronic Pain Remains Inadequate The Lancet (free abstract) Share
Treatment of chronic pain today remains strikingly inadequate, despite better understanding of the underlying pathology and an ever-widening range of therapeutics, according to an overview of the literature. Authors surveyed the literature for systematic reviews, meta-analyses, and guidelines on osteoarthritis, neuropathic pain, fibromyalgia, and low-back pain, and found that opioids were the most commonly prescribed drugs, with sales that increased by more than 175 percent between 1997 and 2006. Yet, these agents were associated with only small improvements in pain and function. More  Kratom? Never Heard of It? Trust Us, You Will The Fix Share
A plant from Thailand with opiate-like properties is the latest "designer drug" speeding its way through America. More Marijuana May Be Studied for Combat Disorder The New York Times Share
For years, some veterans groups and marijuana advocates have argued that the therapeutic benefits of the drug can help soothe the psychological wounds of battle. But with only anecdotal evidence as support, their claims have yet to gain widespread acceptance in medical circles. Now, however, researchers are seeking federal approval for what is believed to be the first study to examine the effects of marijuana on veterans with chronic post-traumatic stress disorder. More  Wine Alcohol Strength 'Systematically' Understated on Labeling The Guardian Share
A study of the alcohol content of 129,000 wines from vineyards across Europe and the U.S. over a 16-year period has suggested that many vintners have been "systematically" understating their wines' strength on labels. The American Association of Wine Economists found that 57 percent of the wines analyzed were stronger than declared on the label. More Just 2 Talks With Teens Can Reduce Marijuana Use for At Least a Year Virginia Tech Share
Nearly one-third of high school students in the United States report smoking marijuana. Despite the mixed messages about the safety of marijuana, it is risky behavior for teens. More  Medicare Proposes Coverage for Screening and Counseling for Alcohol Misuse and Screening for Depression Centers for Medicare & Medicaid Services Share
The Centers for Medicare & Medicaid Services proposed to add alcohol screening and behavioral counseling, and screening for depression, to the comprehensive package of preventive services now covered by Medicare. ASAM submitted comments March 18 in favor of the two proposals. More New Jersey Gets Medical Marijuana The Wall Street Journal (subscription required) Share
New Jersey Gov. Chris Christie gave the green light to the state's medical marijuana program, saying he believes the state's narrow initiative would not run afoul of federal prosecutors. New Jersey's six approved dispensaries could be open by the end of 2011. More FDA OKs Nasal Spray for Pain FDA Share
The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy. More 
 Upcoming Events
 Upcoming Chapter Events
|
 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
